Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Omori K, Tsuchida K, Miya A, Shigesawa I, Tsuchida K, Yanagiya S, Kameda H, Yokoyama H, Taneda S, Kurihara Y, Aoki S, Nishimoto N, Atsumi T, Miyoshi H.
Cho KY, et al. Among authors: kawata s.
J Diabetes Investig. 2021 Aug;12(8):1417-1424. doi: 10.1111/jdi.13498. Epub 2021 Feb 5.
J Diabetes Investig. 2021.
PMID: 33421309
Free PMC article.
Clinical Trial.